Medifast, Inc. (OPTAVIA)

Medifast, Inc., founded in 1980, is a publicly traded health and wellness company headquartered in Baltimore, Maryland. Operating primarily under its OPTAVIA brand, the company's core business revolves around providing habit-based and coach-guided lifestyle solutions for weight loss and metabolic health. Its mission is centered on "Lifelong Transformation, One Healthy Habit at a Time," aiming to enrich lives through innovative choices for lasting health.

Medifast's offerings include scientifically developed products, clinically proven plans, and the support of independent OPTAVIA Coaches. These products encompass meal replacements, snacks, and supplements, complemented by the proprietary Habits of Health® Transformational System. The company primarily targets adults aged 30-64 seeking structured weight loss, habit-based lifestyle changes, and accountability, often appealing to health-conscious professionals and those preferring coached programs over self-directed diets.

In recent developments, Medifast announced a strategic shift towards holistic metabolic health, introducing "Metabolic Synchronization™" to address metabolic dysfunction. The company also partnered with LifeMD in December 2023 to integrate clinically supported weight management programs, including access to GLP-1 medications where appropriate. While facing challenges such as declining revenue in Q4 and full-year 2025 due to a decrease in active coaches and the rise of GLP-1 medications, Medifast is focusing on product innovation and coach retention. Nicholas Johnson was appointed President in January 2026 and is slated to succeed current Chairman and CEO Dan Chard in June 2026, signaling a leadership transition amidst these strategic pivots.